Tokyo, Sept. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062919) titled 'Preliminary Investigation of the Effects of a Calcium-Fortified Breakfast on Glucose Tolerance and Lipid Metabolism Indicators (TG/HDL Ratio) in Japanese Adults' on Sept. 15.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - No treatment

Primary Sponsor: Institute - Aikoku Gakuen Junior College

Condition: Condition - Healthy Adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To investigate, through a randomized parallel-group comparative trial, the effects of continued consumption of calcium-fortified granola and milk as breakfast on glycemic indicators (fasting blood glucose and HbA1c) and lipid metabolism indicators (TG, LDL-C, HDL-C, and the TG/HDL ratio) in healthy Japanese adults. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Eat Consuming Calcium Fortified Granola at breakfast Interventions/Control_2 - Eat Granola at breakfast

Eligibility: Age-lower limit - 19 years-old = Gender - Male and Female Key inclusion criteria - 1. Healthy Japanese adults 2. Age: 19 to 65 years 3. BMI: 20 to 30 kg/m2 4. Individuals who skip breakfast or consume only about 100 kcal for breakfast. 5. Individuals who fully understand the study procedures and provide written informed consent Key exclusion criteria - 1. Individuals currently receiving treatment for lifestyle-related diseases, such as diabetes mellitus, dyslipidemia, or hypertension 2. Individuals who regularly use calcium preparations, supplements, or similar products 3. Individuals with allergies to dairy products, wheat, or any ingredients contained in granola 4. Individuals with skin conditions, eczema, or similar conditions at the sensor application site (the back of the upper arm), or those with severe allergies to adhesives such as those used in adhesive bandages 5. Pregnant or breastfeeding individuals 6. Individuals deemed unsuitable for participation by the principal investigator or the study physician Target Size - 30

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 09 Month 01 Day Anticipated trial start date - 2026 Year 09 Month 16 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072037

Disclaimer: Curated by HT Syndication.